Ginkgo Bioworks Holdings (DNA) Change in Acquisitions & Divestments (2021 - 2026)
Ginkgo Bioworks Holdings (DNA) posted Change in Acquisitions & Divestments of $108.2 million for Q1 2026, up 317.69% on a QoQ basis from $25.9 million in Q4 2025.
Ginkgo Bioworks Holdings (DNA) Change in Acquisitions & Divestments (2021 - 2026) Analysis & Trends
Ginkgo Bioworks Holdings' Change in Acquisitions & Divestments history runs 5 years deep, the most recent figure standing at $108.2 million for Q1 2026.
- Quarterly Change in Acquisitions & Divestments changed N/A year-over-year to $108.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $134.1 million (up 2866.96% YoY) and the FY2025 annual result came in at $25.9 million, up 473.11% from the prior year.
- Change in Acquisitions & Divestments was $108.2 million for Q1 2026 at Ginkgo Bioworks Holdings, up from $25.9 million in the prior quarter.
- Across five years, Change in Acquisitions & Divestments topped out at $108.2 million in Q1 2026 and bottomed at -$65.0 million in Q3 2025.
- A 4-year average of $19.8 million and a median of $4.5 million in 2024 frame the typical range for Change in Acquisitions & Divestments.
- Annual changes were most pronounced in 2022 — Change in Acquisitions & Divestments sank 129.13% — and 2025, when it soared 473.11%.
- Ginkgo Bioworks Holdings' Change in Acquisitions & Divestments stood at -$30000.0 in 2022, then jumped by 15163.33% to $4.5 million in 2024, then surged by 473.11% to $25.9 million in 2025, then jumped by 317.69% to $108.2 million in 2026.
- Business Quant data shows DNA's Change in Acquisitions & Divestments at $108.2 million in Q1 2026, $25.9 million in Q4 2025, and -$65.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Ginkgo Bioworks Holdings | 445.24 Mn | 301.37 Mn | 16.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 108.18 Mn |
| Mar 31, 2026 | 108.18 Mn |
| Dec 31, 2025 | 25.90 Mn |
| Dec 31, 2025 | 25.90 Mn |
| Sep 30, 2025 | -64.96 Mn |
| Sep 30, 2025 | -64.96 Mn |
| Jun 30, 2025 | 64.96 Mn |
| Jun 30, 2025 | 64.96 Mn |
| Dec 31, 2024 | 4.52 Mn |
| Dec 31, 2024 | 4.52 Mn |
| Jun 30, 2022 | -30,000.00 |
| Jun 30, 2022 | -30,000.00 |
| Mar 31, 2022 | 58,000.00 |
| Mar 31, 2022 | 58,000.00 |
| Jun 30, 2021 | 103,000.00 |
| Jun 30, 2021 | 103,000.00 |
| Mar 31, 2021 | 99,000.00 |
| Mar 31, 2021 | 99,000.00 |